ESOPAug 7, 2026, 08:06 AM
Taysha Gene Therapies Grants Stock Options, RSUs to New Hire
AI Summary
Taysha Gene Therapies, Inc. announced that its Compensation Committee granted equity awards to one new employee on August 3, 2026. The awards include restricted stock units representing 144,000 shares and an option to purchase 92,400 shares of common stock. These grants were made under the 2023 Inducement Plan to incentivize the new hire, with both RSUs and stock options vesting over four years, subject to continued employment.
Key Highlights
- One new employee received restricted stock units (RSUs) representing 144,000 shares.
- The employee also received an option to purchase 92,400 shares of common stock.
- Grants were made under the Taysha Gene Therapies, Inc. 2023 Inducement Plan.
- RSUs vest in four equal annual installments starting on the first anniversary.
- Stock option exercise price is $5.78, equal to the closing price on the grant date.
- Stock option vests over four years, with 25% on the first anniversary and monthly thereafter.
Price Impact
More from TSHA